Our tools today are absolutely up to the task. Of those deaths, how many of them do you think are in rich countries vs. the rest of the world.

Seventeen of the twenty-two countries that account for 80 percent of the world’s TB burden are classified as low income (GNP per capita of less than US$760, World Bank 2000). Within countries the prevalence of TB is higher among the poor, and other vulnerable groups such as the homeless. Studies in both high income and low-income countries (USA, United Kingdom, Germany, Norway, Vietnam, Mexico and Philippines) reveal significantly higher rates of TB in poor populations (Davies et al. 1999; Grange 1999; Barnes 1998; Tupasi et al. 2000).

The costs for people in low income countries are so high that often they are unattainable

TB patients and households in sub-Saharan Africa often incurred high costs when utilizing TB treatment and care, both within and outside of Directly Observed Therapy Short-course (DOTS) programs. For many households, TB treatment and care-related costs were considered to be catastrophic because the patient costs incurred commonly amounted to 10% or more of per capita incomes in the countries where the primary studies included in this review were conducted.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570447/

This helps the disease spread and fester in these countries. Whereas so called developed nations reap the benefit of something that does not need to be a problem for anyone.